individualized anti-tumor new antigen iNeo-Vac-R01 injection

BIOLOGICAL4 trials

Sponsors

Zhejiang University

Conditions

Advanced Hepatocellular Carcinoma (HCC)Advanced Intrahepatic CholangiocarcinomaPancreatic Cancer MetastaticPancreatic Cancer Non-resectablePancreatic Cancer Resectable

Phase 1

Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.

Not yet recruitingNCT06888648

Zhejiang UniversityPancreatic Cancer Metastatic, Pancreatic Cancer Non-resectable

Start: 2025-04-01End: 2028-04-01Target: 30Updated: 2025-03-21

Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.

Not yet recruitingNCT06888674

Zhejiang UniversityPancreatic Cancer Resectable

Start: 2025-04-01End: 2029-04-01Target: 60Updated: 2025-03-21

Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma

RecruitingNCT06956716

Zhejiang UniversityAdvanced Intrahepatic Cholangiocarcinoma

Start: 2025-04-09End: 2028-04-01Target: 30Updated: 2025-05-04

Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma

RecruitingNCT06995105

Zhejiang UniversityAdvanced Hepatocellular Carcinoma (HCC)

Start: 2025-04-09End: 2028-04-01Target: 30Updated: 2025-05-29